These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7504426)

  • 1. Antenatal screening for Down's syndrome--can we do better?
    Ellis AR
    Ann Clin Biochem; 1993 Sep; 30 ( Pt 5)():421-4. PubMed ID: 7504426
    [No Abstract]   [Full Text] [Related]  

  • 2. Down's syndrome screening in twins.
    Cuckle H
    J Med Screen; 1998; 5(1):3-4. PubMed ID: 9575449
    [No Abstract]   [Full Text] [Related]  

  • 3. hCG, AFP, and uE3 patterns in the 14-20th weeks of Down's syndrome pregnancies.
    Mancini G; Perona M; Dall'Amico CD; Bollati C; Fulvia A; Carbonara AO
    Prenat Diagn; 1992 Jul; 12(7):619-24. PubMed ID: 1380711
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?
    Palomaki GE; Neveux LM; Haddow JE
    J Med Screen; 1996; 3(1):12-7. PubMed ID: 8861045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk estimation in Down's syndrome screening.
    Wald NJ; Hackshaw AK
    Prenat Diagn; 1996 Nov; 16(11):1055-7. PubMed ID: 8953642
    [No Abstract]   [Full Text] [Related]  

  • 10. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of serum markers in antenatal screening for Down's syndrome.
    Wald NJ; Watt HC
    J Med Screen; 1994 Apr; 1(2):117-20. PubMed ID: 8790499
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
    Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening for Down's syndrome.
    Gocze PM; Arany A; Freeman DA
    N Engl J Med; 1992 Dec; 327(27):1951; author reply 1952-3. PubMed ID: 1280772
    [No Abstract]   [Full Text] [Related]  

  • 14. Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome.
    Ogueh O
    Br J Obstet Gynaecol; 1995 Apr; 102(4):349-50. PubMed ID: 7542022
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum screening for Down's syndrome. Vacutainer system can lead to inaccurate results.
    Bartlett WA; Ford C; Jones AF
    BMJ; 1993 Oct; 307(6908):868. PubMed ID: 7691305
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.
    Chang TC; Cheng HH
    Med J Malaysia; 1994 Dec; 49(4):351-4. PubMed ID: 7545778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for Down's syndrome--results of a 3-year study].
    Kimlová I; Procházková
    Ceska Gynekol; 1996 Apr; 61(2):75-8. PubMed ID: 8689003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Down's syndrome.
    Chard T
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):15. PubMed ID: 8706287
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of gestation dating in Down's screening.
    Worthington DJ
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():1-2. PubMed ID: 9022881
    [No Abstract]   [Full Text] [Related]  

  • 20. Antenatal screening for Down's syndrome: where are we and where next?
    Haddow JE
    Lancet; 1998 Aug; 352(9125):336-7. PubMed ID: 9717914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.